Mosaic ImmunoEngineering Inc. (CPMV) › Cash & EquivalentsMosaic ImmunoEngineering Inc. (CPMV) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $8.45M2012: $4.70M2013: $7.57M2014: $4.72M2015: $2.68M2016: $1.16M2017: $979.6K2018: $2.30M2019: $787.1K2020: $352.7K2021: $226.1K2022: $220.6K2023: $156.2K2024: $115.0K2025: $3.6K$3.6K2011Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.6K-96.9%2024$115.0K-26.4%2023$156.2K-29.2%2022$220.6K-2.4%2021$226.1K-35.9%2020$352.7K-55.2%2019$787.1K-65.7%2018$2.30M+134.6%2017$979.6K-15.5%2016$1.16M-56.7%2015$2.68M-43.2%2014$4.72M-37.7%2013$7.57M+61.2%2012$4.70M-44.4%2011$8.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share